Novomics

Developer of a molecular diagnosis system for cancer treatment

placeSeoul, Seoul, South Korea calendar_todayFounded 2010 groups5 employees language novomics.com

Registered entities

Innovation

7 patent families (4 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 127 times.

YearFilings
20183
20193
20202
20213
20223
20233
20243

Investor mix

14 investors on record.

Investor typeCountShare
Venture capital643%
Private equity429%
Bank & private debt17%
Other / undisclosed321%
Coming soon